Medicare Enrolled

Dr. Michele Innocent, NP

Nurse Practitioner - Family · Pompano Beach, FL
Low-engagement
2031 NW 6TH COURT, Pompano Beach, FL 33069
5612895772
In practice since 2017 (9 years)
NPI: 1134666274 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Innocent from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Innocent? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Innocent

Dr. Michele Innocent is a nurse practitioner - family in Pompano Beach, FL, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Innocent received a total of $17,795 from 78 pharmaceutical and/or device companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Innocent is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice $17,795 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$17,795
Total received (2021-2024)
Avg $4,449/year across 4 years
Top 1% in FL for nurse practitioner - family
78
Companies
714
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,815 (77.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,156 (12.1%)
Other
Charitable contributions, space rental, and other categories
$1,445 (8.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$379 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,881
2023
$4,832
2022
$3,842
2021
$2,240

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,034
Janssen Biotech, Inc.
$1,706
Legend Biotech USA Inc.
$1,331
Incyte Corporation
$1,036
Adaptive Biotechnologies Corporation
$924
Merck Sharp & Dohme LLC
$825
AstraZeneca Pharmaceuticals LP
$793
Celgene Corporation
$760
Seagen Inc.
$633
GENZYME CORPORATION
$526
Daiichi Sankyo Inc.
$464
PFIZER INC.
$431
Takeda Pharmaceuticals U.S.A., Inc.
$408
Astellas Pharma US Inc
$341
Amgen Inc.
$322
Karyopharm Therapeutics Inc.
$283
Eisai Inc.
$279
Genentech USA, Inc.
$256
Ipsen Biopharmaceuticals, Inc
$254
Bayer Healthcare Pharmaceuticals Inc.
$239
ABBVIE INC.
$228
Merck Sharp & Dohme Corporation
$227
TerSera Therapeutics LLC
$219
GlaxoSmithKline, LLC.
$193
Lilly USA, LLC
$170
EMD Serono, Inc.
$157
BeiGene USA, Inc.
$127
PUMA BIOTECHNOLOGY, INC.
$127
Mirati Therapeutics, Inc.
$124
Janssen Pharmaceuticals, Inc
$118
ARRAY BIOPHARMA INC
$116
Regeneron Healthcare Solutions, Inc.
$114
Deciphera Pharmaceuticals Inc.
$108
NOVARTIS PHARMACEUTICALS CORPORATION
$104
E.R. Squibb & Sons, L.L.C.
$93
Dendreon Pharmaceuticals LLC
$82
Pharmacyclics LLC, An AbbVie Company
$81
Alexion Pharmaceuticals, Inc.
$77
AVEO Pharmaceuticals, Inc.
$68
SERVIER PHARMACEUTICALS LLC
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
PharmaEssentia USA Corporation
$65
Alnylam Pharmaceuticals Inc.
$63
Bayer HealthCare Pharmaceuticals Inc.
$62
SOBI, INC
$60
Coherus Biosciences Inc.
$55
Foundation Medicine, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$53
Pharmacosmos Therapeutics Inc.
$51
Agios Pharmaceuticals, Inc.
$50
EISAI INC.
$50
ImmunoGen, Inc.
$47
Myriad Genetic Laboratories, Inc.
$46
ADC Therapeutics America, Inc.
$46
Pharmacyclics LLC, an AbbVie Company
$46
Taiho Oncology, Inc.
$44
Dova Pharmaceuticals
$42
Aveo Pharmaceuticals, Inc.
$40
RECORDATI_RARE_DISEASES_INC.
$39
Kyowa Kirin, Inc.
$39
G1 Therapeutics, Inc.
$32
Sumitomo Pharma America, Inc.
$29
Blue Earth Diagnostics Limited
$28
MorphoSys, US Inc.
$28
Gilead Sciences, Inc.
$24
Exelixis Inc.
$24
Acrotech Biopharma Inc.
$24
Puma Biotechnology, Inc.
$20
Acrotech Biopharma LLC
$20
AbbVie Inc.
$17
Heron Therapeutics, Inc.
$16
TAIHO ONCOLOGY, INC.
$15
SHIELD THERAPEUTICS INC
$14
Sobi, Inc
$13
Iovance Biotherapeutics, Inc.
$11
Sirtex Medical Inc
$8
Organon LLC
$5
Clovis Oncology, Inc.
$2
Top 3 companies account for 28.5% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALUNBRIG · Amtagvi · Axumin · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · PreciseTumor · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONVENDI · VPRIV · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in FL.

Looking for a nurse practitioner - family in Pompano Beach?
Compare family nurse practitioners in the Pompano Beach area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
3,071
Per 100K population
157.8
County median income
$74,534
Nearest hospital
HCA FLORIDA NORTHWEST HOSPITAL
3.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Innocent is a nurse practitioner - family, with low-engagement industry engagement in the top 1% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Innocent receive payments from pharmaceutical companies?
Yes. Dr. Innocent received a total of $17,795 from 78 companies across 714 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Innocent) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →